Alteration of WWOX in human cancer, a clinical view

Expression of WW Domain-Containing Oxidoreductase WOX1 in Human Nervous System Tumors

(2015) Ming-Fu Chiang et al.   Analytical Cellular Pathology

Mechanisms of RET signaling in cancer: Current and future implications for targeted therapy

(2014) I. Plaza-Menacho et al.   CELLULAR SIGNALLING

WW domain-containing oxidoreductase’s role in myriad cancers: Clinical significance and future implications

(2014) Aliza Gardenswartz et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors

(2014) Juan Li et al.   International Journal of Biological Sciences

Characterizing WW Domain Interactions of Tumor Suppressor WWOX Reveals Its Association with Multiprotein Networks

(2014) Mohammad Abu-Odeh et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The supposed tumor suppressor gene WWOX is mutated in an early lethal microcephaly syndrome with epilepsy, growth retardation and retinal degeneration

(2014) Ghada Abdel-Salam et al.   Orphanet Journal of Rare Diseases

The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation

(2013) Martial Mallaret et al.   BRAIN

The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma

(2013) Jianning Zhao   Frontiers in Bioscience-Landmark

ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo

(2013) Nicolas Jullien et al.   GENE

Using the molecular classification of glioblastoma to inform personalized treatment

(2013) Adriana Olar et al.   JOURNAL OF PATHOLOGY

ReducedWWOXprotein expression in human astrocytoma

(2013) William Winardi et al.   NEUROPATHOLOGY

The role of the WWOX gene in leukemia and its mechanisms of action

(2013) ZHAOLEI CUI et al.   ONCOLOGY REPORTS

Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients

(2013) ANNA GÖTHLIN EREMO et al.   ONCOLOGY REPORTS

Personalized treatment strategies in glioblastoma: MGMT promoter methylation status

(2013) Niklas Thon et al.   OncoTargets and Therapy

Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapy

(2013) Z Salah et al.   Cell Death & Disease

The Adolescent and Young Adult with Cancer: State of the Art - Bone Tumors

(2013) Nino Rainusso et al.   Current Oncology Reports

Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas

(2013) Ming-Fu Chiang et al.   Frontiers in Oncology

WWOX Protein Expression Varies Among RCC Histotypes and Downregulation of WWOX Protein Correlates with Less-Favorable Prognosis in Clear RCC

(2012) Jen-Tai Lin et al.   ANNALS OF SURGICAL ONCOLOGY

The expression and significance of WWOX and β-catenin in hepatocellular carcinoma

(2012) Yu-Pu Li et al.   APMIS

Overexpression of WW domain-containing oxidoreductase WOX1 preferentially induces apoptosis in human glioblastoma cells harboring mutant p53

(2012) Ming-Fu Chiang et al.   BIOMEDICINE & PHARMACOTHERAPY

Aberrant Expression of WWOX Protein in Epithelial Ovarian Cancer

(2012) Chao Lan et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Conditional inactivation of the mouseWwoxtumor suppressor gene recapitulates the null phenotype

(2012) Suhaib K. Abdeen et al.   JOURNAL OF CELLULAR PHYSIOLOGY

ErbB3 Inhibitory Surrobodies Inhibit Tumor Cell Proliferation In Vitro and In Vivo

(2012) P. K. Foreman et al.   MOLECULAR CANCER THERAPEUTICS

Genetic alterations of WWOX in Wilms’ tumor are involved in its carcinogenesis

(2012) ELŻBIETA PŁUCIENNIK et al.   ONCOLOGY REPORTS

WWOXinduces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721

(2012) Ben-Shun Hu   WORLD JOURNAL OF GASTROENTEROLOGY

WWOX Oxidoreductase - Substrate and Enzymatic Characterization

(2012) A. Saluda-Gorgul et al.   ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES

Molecular pathology and its diagnostic use in bone tumors

(2012) Karoly Szuhai et al.   Cancer Genetics

New insights and clinical advancements in cellular oncology

(2012) Ad Geurts van Kessel   CELLULAR ONCOLOGY

Regulatory Mechanisms of Tumor Suppressor P16INK4Aand Their Relevance to Cancer

(2011) Junan Li et al.   BIOCHEMISTRY

The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium

(2011) J. M. Balko et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features

(2010) Gulnur Guler et al.   BREAST CANCER RESEARCH AND TREATMENT

Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression

(2010) K. C. Kurek et al.   CANCER RESEARCH

WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis

(2010) Adam J.W. Paige et al.   EUROPEAN JOURNAL OF CANCER

WWOXgene and gene product: tumor suppression through specific protein interactions

(2010) Zaidoun Salah et al.   Future Oncology

The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype

(2010) Xiao Wang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Cloning of WWOX gene and its growth-inhibiting effects on ovarian cancer cells

(2010) Zhoufang Xiong et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme

(2010) Katarzyna Kosla et al.   JOURNAL OF NEURO-ONCOLOGY

Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations

(2010) Naoko Maeda et al.   VIRCHOWS ARCHIV

Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma

(2009) Jilong Yang et al.   CANCER LETTERS

WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity In vivo and Decreases Attachment to Fibronectin via Integrin  3

(2009) C. Gourley et al.   CANCER RESEARCH

Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium

(2009) Daekee Lee et al.   JOURNAL OF CLINICAL INVESTIGATION

Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma

(2009) Yongping Cai et al.   JOURNAL OF PATHOLOGY

Inhibition of the Wnt/β-catenin pathway by the WWOX tumor suppressor protein

(2009) N Bouteille et al.   ONCOGENE

Generation and Characterization of Mice Carrying a Conditional Allele of the Wwox Tumor Suppressor Gene

(2009) John H. Ludes-Meyers et al.   PLoS One

Association between CpG Island Methylation of the WWOX Gene and Its Expression in Breast Cancers

(2009) X. Wang et al.   TUMOR BIOLOGY

Clinical Value of Ezrin Expression in Primary Osteosarcoma

(2009) Chan Kim et al.   Cancer Research and Treatment

Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection

(2008) Shu-Chun Chuang et al.   CANCER LETTERS

Osteosarcoma Development and Stem Cell Differentiation

(2008) Ni Tang et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

The WWOX Tumor Suppressor Is Essential for Postnatal Survival and Normal Bone Metabolism

(2008) Rami I. Aqeilan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX

(2008) Ileana Aderca et al.   JOURNAL OF HEPATOLOGY

Genome-wide linkage scan for prostate cancer susceptibility from the university of michigan prostate cancer genetics project: Suggestive evidence for linkage at 16q23

(2008) Ethan M. Lange et al.   PROSTATE